Monthly Archives: October 2012

BMC Medicine at The World Sports Trauma Congress and 7th EFOST Congress

The general health benefits of regular exercise are well known and highly recommended, but increasing levels of sports can also mean an increase in the incidence of sports injuries. Therefore, there has been growing interest in sports trauma treatment and prevention, not just in the elite athlete, but also in the ‘weekend warrior’; a term… Read more »

Current Controlled Trials appoints new advisory board

A new Current Controlled Trials (CCT) advisory board has been appointed as of October 2012, whom we are looking forward to working with on guiding the future development of our trial registration and related publishing services. Some members have been helping us promote and improve the quality of prospective clinical trial registration for many years:… Read more »

Psychological morbidity: life after the ICU

Despite numerous clinical advances in the field of emergency medicine, patients that survive the intensive care unit (ICU) may experience prolonged psychological distress and a decreased quality of life. Although risk factors for adverse psychological outcomes such as depression, anxiety, and posttraumatic stress disorder (PTSD) have been classified, it is not known which factor poses… Read more »

Nobel prize winners a beacon for stem cell research

Congratulations from all at BioMed Central to Sir John Gurdon and Shinya Yamanaka, who share the 2012 Nobel prize in physiology or medicine for “the discovery that mature cells can be reprogrammed to become pluripotent.” Once again, stem cells are a hot topic of conversation! In 1962 John Gurdon demonstrated that adult cells retained all… Read more »

Beyond the genome and onto the web

auditorium

Organising a conference feels a bit like the final stages of a PhD: spending months scouring the scientific literature, a gradual increase in stress levels, followed by three manic days on a diet consisting entirely of coffee. As an organizer of the third Beyond the Genome meeting, hosted by Genome Medicine and Genome Biology and… Read more »

Nutritional supplements for diabetes prevention: hype or hope?

Diabetes

Predictive, preventive and personalized medicine (PPPM) is positioned as one of the key components to the future of patient care. As outlined in an editorial The EPMA Journal, which recently moved from Springer to BioMed Central, aims to promote this paradigm change “from delayed interventional ‘disease care’ to PPPM as the medicine of the future”… Read more »

The September issue of Genome Medicine: Annotate-it, de novo mutations in neurological and psyquiatric diseases, epigenomics of ulcerative colitis, and more

logo

The September issue of Genome Medicine opens with two research highlights discussing recent articles providing novel insights into the pathophysiology and treatment of chronic obstructive pulmonary disease and ulcerative colitis, inflammatory conditions with increasing incidence worldwide. On the topic of chronic obstructive pulmonary disease, Silke Meiners and Oliver Eickelberg discuss a research article published in the… Read more »